Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives.

Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives. - Gastric ESD on thienopyridines study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017078

Enrollment

Registered

2015-04-10

Start date

2015-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric neoplasms

Interventions

Endoscopic submucosal dissection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed as or suspicious of gastric adenoma/adenocarcinoma (cStageIA). 2) More than six months after last PCI. 3) An oral administration of clopidogrel or prasugrel. 4) A treatment for a single lesion. 5) Older than 19 years and younger than 85 years. 6) Performance status of 0-2. 7) Normal liver, renal, and hematological functions. 8) Follow-up of 60 days after treatment. 9) Written informed consent.

Exclusion criteria

Exclusion criteria: 1) Double registration. 2) A past history of coronary stent embolism. 3) A stent located in left main coronary trunk. 4) A past history of irradiation in upper abdomen. 5) A plan of following treatment for esophageal or duodenal lesions. 6) A recent treatment for upper GI lesions within 28 days before registration. 7) A plan of following treatment for upper GI lesions within 28 days after treatment. 8) A systemic administration of steroids or anticoagulants. 9) An administration of NSAID or other antiplatelets that can be withdrawn before treatment. 10) Pregnancy or bleastfeeding. 11) An active bacterial or fungal infection. 12) A poor control of hypertension. 13) A severe respiratory disease. 14) Other conditions that are judged not suitable.

Design outcomes

Primary

Measure	Time frame
Post operative bleeding rate	—

Countries

Japan

Contacts

Public ContactSatoshi Ono

The University of Tokyo Department of Gastroenterology

satoshi-tky@umin.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026